Applicant

Institution

Title

Award

Andersen, Raymond
University of British Columbia
Marine natural product anticancer drug leads

2011/2012 : $140,352
2012/2013 : $139,823
2013/2014 : $140,352

Arrowsmith, Cheryl
Ontario Cancer Institute/PMH
Structure and function of p53 related proteins

2011/2012 : $143,386
2012/2013 : $143,386
2013/2014 : $143,386

Barrera, Maru
Hospital for Sick Children
A randomized control trial to evaluate the efficacy of a social skills intervention group for childhood survivors of brain tumours

2011/2012 : $199,035
2012/2013 : $183,872
2013/2014 : $184,062

Baxter, Nancy
St. Michael's Hospital
Identifying barriers to participation in colorectal cancer screening

2011/2012 : $110,188
2012/2013 : $94,659

Beaulieu, Luc
Laval University
Advanced model-based dose calculations for brachytherapy clinical applications

2011/2012 : $119,520
2012/2013 : $109,440
2013/2014 : $109,440

Bhatia, Mick
McMaster University
Characterization of hedgehog regulation during definitive hematopoiesis from reprogrammed adult human skin stem cells

2011/2012 : $141,000
2012/2013 : $141,000
2013/2014 : $141,000

Blencowe, Benjamin
University of Toronto 
Identification and characterization of alternative splicing regulatory networks mis-regulated in cancer

2011/2012 : $142,866
2012/2013 : $143,731
2013/2014 : $141,600

Bremner, Rod
The Toronto Hospital (Western Division)
Hierarchical control of interferon-gamma signalling

2011/2012 : $144,000
2012/2013 : $144,000
2013/2014 : $144,000

Chan, Kelvin
Sunnybrook Research Institute
A population study on discontinuation of adjuvant trastuzumab in breast cancer

2011/2012 : $37,871
2012/2013 : $44,423

Cheung, Angela
The Toronto Hospital (General Division)
Effects of exemestane on bone strength in postmenopausal women at increased risk for developing breast cancer - an extension of the MAP3BSS companion study

2011/2012 : $275,447
2012/2013 : $178,373
2013/2014 : $178,372

Cheung, Winson
BC Cancer Agency (Vancouver)
Utilization and quality of preventive health care among adult cancer survivors

2011/2012 : $137,965
2012/2013 : $136,837
2013/2014 : $118,037

Dankort, David
McGill University
Targeting the PTEN/PI3K signalling cascade in BrafV600E-induced malignant melanoma
* The Melanoma Research Alliance is contributing an additional $125,000 towards this grant

2011/2012 : $112,240
2012/2013 : $112,240
2013/2014 : $112,240

Devins, Gerald
Ontario Cancer Institute/PMH
A new psychoeducational intervention to minimize illness intrusiveness in head and neck cancer

2011/2012 : $113,939
2012/2013 : $105,967
2013/2014 : $105,967

Dick, Frederick
University of Western Ontario
The role of negative growth regulation by the retinoblastoma protein and transforming growth factor-ß in suppression of mammary tumorigenesis

2011/2012 : $126,571
2012/2013 : $126,571
2013/2014 : $126,571

Dick, John
Ontario Cancer Institute/PMH
Characterization of the role of leukemic stem cells in human leukemogenesis

2011/2012 : $144,000
2012/2013 : $144,000
2013/2014 : $144,000

Drobetsky, Elliot
University of Montreal
Molecular basis of defective nucleotide excision repair in malignant melanoma

2011/2012 : $135,360
2012/2013 : $135,360
2013/2014 : $135,360

Fagotto, François
McGill University
Role of the tumour-associated EpCAM in cell motility and cell-cell adhesion during morphogenesis

2011/2012 : $144,000
2012/2013 : $144,000
2013/2014 : $144,000

Forman-Kay, Julie
Hospital for Sick Children
Understanding how multi-site phosphorylation regulates cell cycle

2011/2012 : $132,480
2012/2013 : $132,480
2013/2014 : $132,480

Fu, YangXin
University of Alberta
Nitric oxide/soluble guanylyl cyclase signalling pathway in epithelial ovarian cancer

2011/2012 : $140,804
2012/2013 : $140,804
2013/2014 : $140,804

Gallinger, Steven
Mount Sinai Hospital
Exome sequencing of familial colorectal cancer type x

2011/2012 : $141,000
2012/2013 : $141,000
2013/2014 : $137,240

Gorczynski, Reginald
The Toronto Hospital (General Division)
Do CD200:CD200R interactions regulate local/metastatic breast cancer growth?

2011/2012 : $125,189
2012/2013 : $125,189
2013/2014 : $125,189

Greer, Peter
Queen's University
Targeting the Fes tyrosine kinase in breast cancer

2011/2012 : $140,160
2012/2013 : $140,160
2013/2014 : $140,160

Harris, Shelley
Cancer Care Ontario
Exposures to emerging environmental contaminants and risk of breast cancer in young women: a case-control study using biomarkers of exposure

2011/2012 : $282,000
2012/2013 : $282,000
2013/2014 : $282,000

Haston, Christina
McGill University
Inflammatory composition of radiation-induced lung disease

2011/2012 : $131,616
2012/2013 : $134,352
2013/2014 : $133,632

Hui, Chi-chung
Hospital for Sick Children
Hedgehog signalling in skin development and tumorigenesis

2011/2012 : $144,000
2012/2013 : $144,000
2013/2014 : $144,000

Irwin, Meredith
Hospital for Sick Children
Novel therapies for neuroblastoma

2011/2012 : $143,434
2012/2013 : $143,434
2013/2014 : $143,434

Jirik, Frank
University of Calgary
Identifying factors responsible for enhancing the metastatic potential of xenografted NSCLC cells

2011/2012 : $140,764
2012/2013 : $140,764
2013/2014 : $140,764

King, Will
Queen's University
Meat-derived carcinogens and colorectal adenoma risk

2011/2012 : $94,160
2012/2013 : $79,538

Koromilas, Antonis
Jewish General Hospital
Control of cellular senescence by the eIF2alpha phosphorylation pathway

2011/2012 : $144,000
2012/2013 : $144,000
2013/2014 : $144,000

Li, Gang
University of British Columbia
The role of ING tumour suppressors in nucleotide excision repair

2011/2012 : $141,000
2012/2013 : $141,000
2013/2014 : $141,000

Maddox, Paul
University of Montreal
Mechanisms of centromere specification and function

2011/2012 : $143,040
2012/2013 : $143,040
2013/2014 : $143,040

Marshall, Aaron
University of Manitoba
Phosphoinositide-dependent signalling pathways in B cell leukemia

2011/2012 : $139,657
2012/2013 : $139,660
2013/2014 : $139,660

McIntosh, Lawrence
University of British Columbia
Regulation of ETS transcription factors

2011/2012 : $143,904
2012/2013 : $143,904
2013/2014 : $143,904

Meguerditchian, Ari-Nar
Royal Victoria Hospital (Montreal)
Adjuvant endocrine therapy in breast cancer: a novel approach in monitoring long term treatment adherence in seniors

2011/2012 : $69,141
2012/2013 : $55,498

Ménard, Cynthia
Ontario Cancer Institute/PMH
Tumour-targeted radiotherapy for prostate cancer

2011/2012 : $218,680
2012/2013 : $263,330
2013/2014 : $263,330

Momparler, Richard
CHU Sainte-Justine Research Centre (U of Montreal)
Experimental chemotherapy of leukemia

2011/2012 : $105,984
2012/2013 : $105,984
2013/2014 : $105,984

Ostergaard, Hanne
University of Alberta
Signals controlling dynamic interactions of cytotoxic T lymphocytes

2011/2012 : $144,000
2012/2013 : $144,000
2013/2014 : $144,000

Roux, Philippe
University of Montreal
Mitogenic and oncogenic regulation of RSK signalling

2011/2012 : $144,000
2012/2013 : $144,000
2013/2014 : $144,000

Rutka, James
Hospital for Sick Children
Blockade of aberrant HGF/cMET signalling in medulloblastoma

2011/2012 : $144,000
2012/2013 : $144,000
2013/2014 : $144,000

Sauvageau, Guy
Inst. de rech. en imm/cancer (IRIC)- U of Montreal
PRC2 activity in normal and cancer stem cells

2011/2012 : $141,000
2012/2013 : $141,000
2013/2014 : $141,000

Seow, Hsien
McMaster University
The organization, delivery and costs of end-of-life cancer care: the potential of homecare nursing in four provinces

2011/2012 : $195,036
2012/2013 : $270,872
2013/2014 : $205,707

Siegel, Peter
McGill University
ShcA-dependent mechanisms driving breast cancer cell migration and invasion

2011/2012 : $140,850
2012/2013 : $140,850
2013/2014 : $140,850

Stambolic, Vuk
Ontario Cancer Institute/PMH
Characterization of nuclear PTEN and its role in the maintenance of genomic integrity and cancer

2011/2012 : $137,710
2012/2013 : $137,710
2013/2014 : $137,710

Stanford, William
University of Toronto
The role of PCL2 in regulating gene expression and proliferation in vivo

2011/2012 : $142,080
2012/2013 : $142,080
2013/2014 : $142,080

Tremblay, Michel
McGill University
Understanding and targeting TC-PTP in immune diseases and cancer

2011/2012 : $110,668
2012/2013 : $112,800
2013/2014 : $112,800

Trimble, William
Hospital for Sick Children
Septins as a signalling platform for cancer and metastasis

2011/2012 : $144,000
2012/2013 : $144,000
2013/2014 : $144,000

Tsao, Ming-Sound
Ontario Cancer Institute/PMH
Functional genomics and in vitro modelling of human pancreatic carcinogenesis

2011/2012 : $135,689
2012/2013 : $135,689
2013/2014 : $138,255

Valliant, John
McMaster University
Development of a molecular imaging probe for the insulin receptor

2011/2012 : $137,464
2012/2013 : $137,464
2013/2014 : $137,464

Vanderhyden, Barbara
Ottawa Hospital Research Institute
Roles of BRCA1 and PAX2 in the initiation of ovarian cancer

2011/2012 : $138,473
2012/2013 : $138,473
2013/2014 : $138,473

Wilde, Andrew
University of Toronto
The role of chromosomal signals in cell division

2011/2012 : $144,000
2012/2013 : $144,000
2013/2014 : $144,000

Zemp, Roger
University of Alberta
Realtime functional optical-resolution photoacoustic microscopy and micro-endoscopy for cancer research and diagnosis

2011/2012 : $122,270
2012/2013 : $122,270
2013/2014 : $122,270

Zimmermann, Camilla
Ontario Cancer Institute/PMH
Randomized trial of an early palliative care team intervention for patients with metastatic cancer: effects on aggressiveness of care, quality of death and caregiver bereavement

2011/2012 : $215,025
2012/2013 : $210,153
2013/2014 : $235,390